Article thumbnail

Coste por paciente con respuesta a romiplostim y rituximab en el tratamiento de la trombocitopenia inmune primaria en España

By María Fernanda López Fernández
Publisher: 'Elsevier BV'
Year: 2015
DOI identifier: 10.1016/j.medcli.2013.11.035
OAI identifier:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.